Maryland Goes a Step Further to Rein in Drug Price Spikes image

Regulatory Affairs Professionals Society (RAPS), February 27, 2017
Zachary Brennan, citing Rachel E. Sachs (Academic Fellow Alumna)


Read the Full Round-Up

[...] The bill has drawn criticism from industry groups and others who say such independent audits would be overly burdensome for industry and that the $2500 threshold might include too many drugs as other states have included a $10,000 threshold, though other experts think the legislation is a step in the right direction. [...]

health care finance health law policy pharmaceuticals public health rachel sachs regulation